Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Apr 12, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it plans to issue its 2017 first quarter financial results before the opening of the market on Thursday, April 20, 2017. The Company will host a conference call at 8:00 a.m., Eastern Time on April 20, 2017 to discuss its ...
Mar 15, 2017 Waltham-based company to exhibit its wearable device for widespread pain relief ORLANDO, Fla.--(BUSINESS WIRE)-- Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell®, its FDA-cle...
Mar 1, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New G...
Feb 21, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell® will be available in over 450 Best Buy® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.com. "More and more consumers are proactively looking for techno...
Jan 26, 2017 2016 revenue $12.0M up 65% year-on-year; Q4 revenue $3.7M up 36% Quell device shipments of 14.3K and electrode reorders of 20K represent new quarterly highs WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial a...
Jan 20, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017. The Company will host a conference call at 8:00 a.m., Eastern Time on January 26, 2017 to ...
Jan 10, 2017 Invoiced Value of Quell Shipments Up 19% Over Q3 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell® Wearable Pain Relief Technology™. During Q4 2016 the invoiced value of Quell shipments ...
Jan 6, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ:NURO, NUROW) today announced that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, is scheduled to speak at the Digital Medicine Showcase 2017 at the Parc 55 San Francisco in San Francisco, CA. The Digital Medicine Showcase brings ...
Jan 5, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced that it has closed its previously announced private placement to a healthcare dedicated institutional investor of 7,000 shares of Series E convertible preferred stock at a price of $1,000 per share, and warrants to purchase an ...
Jan 3, 2017 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) announced today that Shai N. Gozani M.D., Ph.D., President and Chief Executive Officer, will be presenting at the Biotech Showcase 2017 Conference being held at the Hilton San Francisco Union Square in San Francisco, CA. Dr. Gozani...
Jan 3, 2017 Company unveils advanced product features for Quell Wearable Pain Relief Technology at CES 2017, booth #43421 LAS VEGAS--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq:NURO, NUROW) today announced plans to unveil important advances to its Quell® Wearable Pain Relie...
Dec 28, 2016 Will not complete previously announced registered offering WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it has entered into a definitive securities purchase agreement with a healthcare dedicated institutional investor in connection with a pri...
Dec 22, 2016 Company to Unveil Innovative Upgrades for Quell Wearable Pain Relief Technology LAS VEGAS--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) Building on sales to over 50,000 chronic pain sufferers who have tried Quell® since its launch in June 2015, NeuroMetrix...
Dec 20, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. ("NeuroMetrix" or the "Company") (NASDAQ: NURO, NUROW) announced today the pricing of a public offering with expected gross proceeds from the offering of $26.5 million. The offering was priced at $0.70 per share of the Company's common stock (or common stock ...
Dec 15, 2016 WALTHAM, Mass.--(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW) reported increased media attention on the company's Quell® Wearable Pain Relief Technology™, including an in depth report on CBS's Innovation Nation. Highlights include: CBS Innovation Nation - The ...
= add release to Briefcase